Bioscience Neutraceuticals Inc. (fka DEVV)

[Werbe]

Both of these have revoked licenses in Nevada and JBCT is now delinquent in filings. Total Liabilities here are around 150k. That is good 2 build off of. Tight float also held by Chen.

Share Count as of 09/04/2018

Authorized Shares 150,000,000

Outstanding Shares 9,700,000

Restricted 8,200,000

Float 1,500,000

52-Wk Range
0.10 - 13.00

As of April 27, 2017, Omri Morchi and Eden Shoua (the “Sellers”), entered into a Common Stock Purchase Agreement (the “Stock Purchase Agreement”) pursuant to which the Sellers agreed to sell to Peak Global Consultants Limited (the “Purchaser”), the 8,000,000 shares of common stock of the Company (the “Shares”) owned by the Sellers, constituting approximately 84.2% of the Company’s 9,500,000 issued and outstanding common shares, for $235,000. As a result of the sale there was a change of control of the Company, effective as of May 12, 2017. There is no family relationship or other relationship between the Sellers and the Purchaser.

In connection with the sale, pursuant to the Stock Purchase Agreement, the Sellers and the Company’s Directors and officers—Mr. Morchi and Ms. Shoua--agreed to (a) appoint Liang Chen (the “Designee”) as the sole director of the Company, subject to the filing and dissemination of this Information Statement, and (b) submit their resignations as the directors and officers of the Company. As a result thereof, the Designee is now the sole director of the Company.

As of the date of this Form 8-K, the authorized capital stock of the Company consists of 100,000,000 shares of common stock, par value $.0001 per share, of which 9,500,000 shares are issued and outstanding, and 50,000,000 shares of Preferred Stock, $.0001 par value, none of which shares are issued or outstanding. Each share of common stock is entitled to one vote with respect to all matters to be acted on by the stockholders.

On July 10, 2017, the Company acquired all of the shares of Bio Health Products Inc. a Nevada corporation, in exchange for 200,000 shares of the Company’s common stock, whereby Bio Health Products Inc. became a wholly owned subsidiary of the Company. Bio Health Products Inc. had previously acquired the assets of Essential Oils, a sole proprietorship. Bio Health Products Inc. was owned by Liang Chen, the CEO of the Company.

https://www.otcmarkets.com/stock/JBCT/security